Zest Health | $13,000,000 | (Feb 4, 2025)
Gallabox | $3,500,000 | (Feb 4, 2025)
Diag-Nose.io
Australia
- Melbourne, VIC
- 04/02/2025
- Seed
- $2,000,000
Diag-Nose.io, founded in 2020 and headquartered in Melbourne, Australia, is a biotechnology company focused on translating the complexities of the unified airway into precision diagnostic and drug discovery solutions.
Their precision medicine technology combines advanced proteomics, computational biology, and AI (machine learning) to create a scalable respiratory biology model. This innovation aims to help clinicians prescribe the right treatments faster and enable researchers to accelerate the development of new therapies.
The company’s flagship platform, RhinoMAP™, leverages proteomic data to predict respiratory disease activity, monitor therapy response and predict treatment efficacy in advance, with an initial focus on anti-Th2 biologics.
- Industry Biotechnology Research
- Website https://diag-nose.io/
- LinkedIn https://www.linkedin.com/company/diagnose-io/
Related People
Eldin RostomCo Founder
Australia -
ND
I deeply believe in building companies underpinned by breakthrough science for the betterment of humankind.
My mantra is "founders of the future need to build with atoms, not just bytes"; because the biggest problems of our planet cannot be solved by software alone.
Current focus in healthcare stemming from a personal history of neurological problems/seizures and partial blindness.
Lula – Reinventing Property Maintenance | $28,000,000 | (Feb 4, 2025)
Tana | $14,000,000 | (Feb 4, 2025)
Affineon Health | $5,000,000 | (Feb 4, 2025)
Yavrio - Open Banking | $2,359,724 | (Feb 4, 2025)
Vetigenics | $6,000,000 | (Feb 4, 2025)
Semeris - Legal AI for Finance | $4,300,000 | (Feb 4, 2025)
Medsender | $5,000,000 | (Jan 31, 2025)
Seraphic Security | $29,000,000 | (Jan 31, 2025)
Athenic AI | $4,300,000 | (Jan 31, 2025)